CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2015; 02(02): 162
DOI: 10.1055/s-0038-1667533
Abstracts
Thieme Medical and Scientific Publishers Private Ltd.

Effect of dexmedetomidine for ICU sedation in head injury patients

Sujoy Banik
1   Department of Neuroanaesthesiology, All India Institute of Medical Sciences, New Delhi, India
,
Ashish Bindra
1   Department of Neuroanaesthesiology, All India Institute of Medical Sciences, New Delhi, India
,
Varun Jain
1   Department of Neuroanaesthesiology, All India Institute of Medical Sciences, New Delhi, India
,
Keshav Goyal
1   Department of Neuroanaesthesiology, All India Institute of Medical Sciences, New Delhi, India
,
Niraj Kumar
1   Department of Neuroanaesthesiology, All India Institute of Medical Sciences, New Delhi, India
,
Girija P. Rath
1   Department of Neuroanaesthesiology, All India Institute of Medical Sciences, New Delhi, India
› Institutsangaben
Weitere Informationen
[Abstracts published in the Journal of Neuroanaesthesiology and Critical Care have not been reviewed by the Editorial Board of the Journal. These abstracts were presented at the annual meet of ISNACC and selected by the organizers and the scientific committee of the Society]

Publikationsverlauf

Publikationsdatum:
13. Juli 2018 (online)

 

    Introduction: Although neuro-intensive patients share many goals with general ICU patients, some indications are unique to the NICU population, such as maintaining adequate cerebral perfusion pressure (CPP), while controlling intracranial pressure (ICP) and mean arterial pressure (MAP). Materials and Methods: We compared the effect of 0.2–0.7 μg/kg/hr dexmedetomidine infusion to a standard sedative infusion of fentanyl 0.2–1 μg/kg/hr and midazolam 0.02–0.07 mg/kg/hr in 11 consecutive patients of Traumatic Brain Injury (TBI) admitted to the neurosurgical intensive care unit (NICU) in crossover alternation for the first 48 hours after admission, titrating sedation to the Richmond Agitation-Sedation Scale (RASS). Results: Patient demographics were well matched between the two groups. Hemodynamics (HR, MAP) and intracranial pressure (ICP) along with cerebral perfusion pressure (CPP) were well maintained within (P = 0.472, 0.219, 0.328, and 0.165) and between both the groups (P = 0.096, 0.432, 0.478, 0.175 respectively) and the differences were not statistically significant [Figures 2-4]. Patients in Group D had similar RASS scores to those of Group C (P = 0.894) [Figure 5]. GCS was positively correlated with RASS in Group D (P = 0.467, P = 0.021) and Group C (P = 0.654, P = 0.001). Amount and number of rescue boluses of sedation with midazolam were similar in both the groups (n = 3, P = 0.463), nor any adverse effects seen in either group. Conclusion: Dexmedetomidine is a safe alternative to conventional fentanyl and midazolam sedative infusion for TBI patients admitted to Neurosurgical Intensive Care Unit, maintaining both cardiovascular (HR, MAP) as well as cerebral (ICP, CPP) dynamics, paving the way for future exploration of dexmedetomidine for sedation for neurosurgical ICU patients.


    #

    Die Autoren geben an, dass kein Interessenkonflikt besteht.

    [Abstracts published in the Journal of Neuroanaesthesiology and Critical Care have not been reviewed by the Editorial Board of the Journal. These abstracts were presented at the annual meet of ISNACC and selected by the organizers and the scientific committee of the Society]